Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-26-002306
Filing Date
2026-04-20
Accepted
2026-04-20 19:24:03
Documents
1
Period of Report
2026-04-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 19198
  Complete submission text file 0000919574-26-002306.txt   22316
Mailing Address BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Reporting) CIK: 0001278386 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 26876430

Mailing Address 156 WEST 56TH STREET 3RD FLOOR NEW YORK NY 10019
Business Address 156 WEST 56TH STREET 3RD FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD CAPITAL INC (Reporting) CIK: 0001278387 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 26876429

Mailing Address 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019
Business Address
Bradsher Neal C (Reporting) CIK: 0001278388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 26876428

Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Issuer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)